What do we know about self-medication with psychoactive drugs? A reading from neuroenhancement
DOI:
https://doi.org/10.35319/ajayu.211109Keywords:
Self medication, medicalization, neuroenhancement, Self medicalization, psychopharmaceuticalAbstract
This work is proposed as a conceptual framework that seeks to contribute to the understanding and research of the problem of self-medication with psychoactive drugs, in particular, the case of neuroenhancement. This phenomenon involves various problems, categories and edges that prevent it from being reduced to any particular analysis. The analysis from medicalization and social control is a contribution, but it is insufficient to understand the heterogeneity of this phenomenon. On the other hand, the analyzes from the moral discussion on the non-medical use of medical technologies, likewise, which, from the perspective of risk, elude the contingent nature of the use of psychoactive drugs on their own. Particularly the practice of neuroenhancement, from the perspective of use, shows how moral dilemmas are overcome by a pragmatic approach at the time of choosing to resort to the drug, from a theoretical point of view. It problematizes how the concepts of self-medication and medicalization can be put in tension, that is why it will be taken as a model of self-medicated practice, for the development of this work.
Downloads
References
Barad, K. (1996). Meeting the universe halfway: realism and social constructivism without contradiction". L. H. Nelson (eds) Feminism, science, and the Philosphy of Science, 161-194. Kluwen.
Bard, I., Gaskell G. & Allansdottir, A. (2018). Bottom Up Ethics - Neuroenhancement in Education and Employment. Neuroethics 11, 309–322 (2018). https://doi.org/10.1007/s12152-018-9366-7.
Barrera-Herrera, A. & San Martín, Y. (2021). Prevalencia de Sintomatología de Salud Mental y Hábitos de Salud en una Muestra de Universitarios Chilenos. Psykhe, 30(1). https://doi.org/10.7764/psykhe.2019.21813
Béhague, DP. (2013) “Unconventional Psychiatric Medico-Politicization: The Making and Unmaking of Behavioural Disorders in Pelotas, Brazil” In Troubling Natural Categories: Engaging the Medical Anthropology of Margaret Lock. Naomi Adelson and Pam Wakewich, McGill-Queen’s University Press.
Bianchi, Eugenia. (2018). Saberes, fármacos y diagnósticos. Un panorama sobre producciones recientes en torno a la farmacologización de la sociedad. https://doi.org/10.26864/pcs.v8.n2.11
Boric, N. (2020). Formas de sujeción en el uso crónico de benzodiacepinas en pacientes atendidos en contextos de salud pública Consideraciones psicoanalíticas sobre un objeto difuso [Tesis Magister en Psicología Clínica de Adultos, Universidad de Chile]. http://repositorio.uchile.cl/handle/2250/178599
Collin, J., & Otero, M. (2006). Le médicament au coeur de la socialité contemporaine. Presses de l'Université du Québec.
Conrad. (2013). Medicalization: Changing Contours, Characteristics, and Contexts. In Medical Sociology on the Move (pp. 195–214). Springer Netherlands. https://doi.org/10.1007/978-94-007-6193-3_10
Droguett, N., Vidal C., Medina B. & Hoffmeister L. (2019). Factores asociados al consumo de psicofármacos sin receta en Chile: estudio descriptivo basado en la Encuesta Nacional de Consumo de Drogas en Población General.Medwave, 19(6): 7670 https://doi.org/10.5867/medwave.2019.06.7670
Ehrenberg A. (2020). The mechanics of passions. Brain, behaviour, and society. McGill-Queen’s University Press.
Escobar-Salinas, Jorge & Rios, Carlos. (2017). Automedicación en adultos de 11 ciudades de Latinoamérica, 2015-2016: estudio multicéntrico. CIMEL. 22. 2017. https://oaji.net/articles/2017/6297-1531095800.pdf
European Monitoring Centre for Drugs and Drug Addiction (2020), Impact of COVID-19 on patterns of drug use and drug-related harms in Europe. EMCDDA.
Fainzag. S. (2012). L’automédication ou les mirages de l’autonomie. Paris, Presses universitaires de France. https://doi.org/10.3917/puf.fain.2012.01
Fainzang, S. (2011) From self-diagnosis to self-medication : constructing and identifying symptoms. S. Fainzang; C. Haxaire. Of Bodies and Symptoms. Anthropological Perspectives on their Social and Medical Treatment, URV Publicacions, pp.39-58, 2011. ⟨hal-03707502⟩
Fainzag, S. (2013) The Other Side of Medicalization: Self-Medicalization and Self-Medication. Cult Med Psychiatry 37:488-504. https://doi.org/10.1007/s11013-013-9330-2
Fritsch, R., Galleguillos, T., Gaete, J. & Araya B, (2004). Consumo de psicofármacos en la población general del Gran Santiago, Chile. Revista de psiquiatría clínica, 41(2), 15-24.
Forlini, C. Schildmann, J. Roser, P. Beranek, R & Vollmann, J. (2014). Knowledge, Experiences and Views of German University Students Toward Neuroenhancement: An Empirical- Ethical Analysis. Neuroethics. 8. 1-10. https://doi.org/10.1007/s12152-014-9218-z.
Foucault, M. (2006). Seguridad, territorio, población. FCE.
Hacking, Ian. (2004). Between Michel Foucault and Erving Goffman: Between Discourse in the Abstract and Face-to-Face Interaction. Economy and Society. 33. 277-302. https://doi.org/10.1080/0308514042000225671
Illich, I. (1975). Ne´me´sis me´dicale. L’expropriation de la sante´. Seuil.
Jenkins, H. (2013), Pharmaceutical Self: The Global Shaping of Experience in an Age of Psychopharmacology. Transcultural Psychiatry ;50(4):599-604. https://doi.org/10.1177/1363461513504858
Kitanaka J. (2011). Depression in Japan: Psychiatric cures for a society in distress. Princeton Uniersity Press.
Lemieux, C. (2018). La sociologie pragmatique. La Découverte.
Moncrieff, J. (2020). Not in our Brains: On the Complex Relationship Between Biology and Behavior. Philosophy, Psychiatry, & Psychology 27(3), 321-323. https://doi.org/10.1353/ppp.2020.0039.
National Institute on Drug Abuse. (2012). Principles of Drug Addiction Treatment. A research- Based Guide (3rd ed.). NIH Publication.
Organización Mundial de la Salud. (2002) Perspectivas políticas sobre medicamentos de la OMS— Promoción del uso racional de medicamentos: componentes centrales. Ginebra. Disponible en URL: https://apps.who.int/iris/bitstream/handle/10665/67532/WHO_EDM_2002.3_spa.pdf (último acceso marzo 2015)
Pharmaceutical Group of European Union (2018) The effects of deregulation of distribution channels for non-prescription medicines in Europe. Disponible en https://www.pgeu.eu/wp-content/uploads/2019/07/180516E-PGEU-Position-Paper-on-the-effects-of-deregulation-of-NPMs-distribution-channels.pdf (Mayo; 2018)
Petryna A., Lakoff A. & Kleinman A. (2006). Global pharmaceuticals: ethics, markets, practices. Duke University Press.
Reyes, P, Jiménez, A. Cottet, P. & Jauregui, G. (2019). Rethinking medicalization: discursive positions of children and their caregivers on the diagnosis and treatment of ADHD in Chile. Saúde e Sociedade [online]. 2019, v. 28, n. 1 [Accedido 11 Enero 2023], pp. 40-54. Disponible en: https://doi.org/10.1590/S0104-12902019181141
Romero, M., Santander, J., Hitschfeld, M., Labbé, M. & Zamora, V. (2009). Consumo de tabaco y alcohol entre los estudiantes de medicina de la Pontificia Universidad Católica de Chile. Revista médica de Chile, 137(3), 361-368. https://doi.org/10.4067/S0034-98872009000300006
Rojas, S. & Vrecko, S. (2017). Pharmaceutical entanglements: an analysis of the multiple determinants of ADHD medication effects in a Chilean school. International Journal of Qualitative Studies on Health and Well-Being. 12. 1-10. https://doi.org/10.1080/17482631.2017.1298268.
Rojas, S. (2019). Medicalisation in neoliberal contexts: imagining other futures in schools. Práxis Educacional, [S. l.], v. 15, n. 36, p. 265-284, 2019. DOI: 10.22481/praxisedu.v15i36.5886. Disponível em: https://periodicos2.uesb.br/index.php/praxis/article/view/5886. Acesso em: 11 jan. 2023.
Rose, N. & Abi-Rached, J. (2013). Neuro: The New Brain Sciences and the Management of the Mind. http://doi.org/10.1590/1807-57622015.0169
Rose, N. (2020). Nuestro futuro psiquiátrico. Editorial Morata.
Singh, I., & Kelleher, K.J. (2010). Neuroenhancement in young people: Proposal for research, policy, and clinical management. Ajob Neuroscience 1 (1): 3–16. https://doi.org/10.1080/21507740903508591
Singh I, Kendall T, Taylor C, Mears A, Hollis C, Batty & M, Keenan S. (2010) Young People's Experience of ADHD and Stimulant Medication: A Qualitative Study for the NICE Guideline. Child Adolesc Ment Health. Nov;15(4):186-192. https://doi.org/10.1111/j.1475-3588.2010.00565.x. PMID: 32847199.
Singh I. Bard I. & Jackson J. (2014). Robust Resilience and Substantial Interest: A Survey of Pharmacological Cognitive Enhancement among University Students in the UK and Ireland. PLoS ONE 9(10): e105969. https://doi.org/10.1371/journal.pone.0105969
Smith ME & Farah MJ. Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol Bull. 2011 Sep;137(5):717-41. https://doi.org/10.1037/a0023825. PMID: 21859174; PMCID: PMC3591814.
Vargo, EJ & Petróczi A. (2016). "It Was Me on a Good Day": Exploring the Smart Drug Use Phenomenon in England. Front Psychol, 7, 779. https://doi.org/10.3389/fpsyg.2016.00779
Vidal, F & Ortega, F. (2021). ¿Somos nuestro cerebro? La construcción del sujeto cerebral. Alianza Editorial.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Revista AJAYU
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
De acuerdo a la Ley 1322 de Derechos de Autor en Bolivia, la revista de psicologia AJAYU respeta los derechos morales de los autores, amparando la parternidad e integridad de sus obras publicadas.